CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
Vatankhah M, Azizi A, Sanajouyan Langeroudi A, Ataei Azimi S, Khorsand I, Kerachian MA, Motaei J.
Vatankhah M, et al.
Crit Rev Clin Lab Sci. 2021 Jun;58(4):225-241. doi: 10.1080/10408363.2020.1849010. Epub 2020 Nov 27.
Crit Rev Clin Lab Sci. 2021.
PMID: 33245685
Review.
The biosensing systems have several important features that make them suitable for point-of-care tests, including the speed of design and synthesis of each platform in less than a few days, an assay time of 1-2 h, and the cost of materials and reagents less than one dollar …
The biosensing systems have several important features that make them suitable for point-of-care tests, including the speed of design and sy …